Hitech vs Wockhardt Which Is More Reliable?

Hitech and Wockhardt are two prominent pharmaceutical companies in the Indian market. While both companies operate in the same industry, their performance and outlook differ significantly. Hitech has shown consistent growth in recent years, with a strong focus on innovation and research. On the other hand, Wockhardt has faced challenges related to regulatory issues and financial struggles. Investors interested in these stocks should carefully analyze their financials, competitive position, and long-term growth prospects before making investment decisions.

Hitech or Wockhardt?

When comparing Hitech and Wockhardt, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Hitech and Wockhardt.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Hitech has a dividend yield of 0.4%, while Wockhardt has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Hitech reports a 5-year dividend growth of 2.13% year and a payout ratio of 0.00%. On the other hand, Wockhardt reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Hitech P/E ratio at 26.91 and Wockhardt's P/E ratio at -72.59. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Hitech P/B ratio is 1.59 while Wockhardt's P/B ratio is 6.16.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Hitech has seen a 5-year revenue growth of 0.22%, while Wockhardt's is -0.44%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Hitech's ROE at 6.04% and Wockhardt's ROE at -8.32%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ₹247.25 for Hitech and ₹1347.15 for Wockhardt. Over the past year, Hitech's prices ranged from ₹179.90 to ₹351.35, with a yearly change of 95.30%. Wockhardt's prices fluctuated between ₹376.45 and ₹1466.95, with a yearly change of 289.68%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.